A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00558675
Recruitment Status : Completed
First Posted : November 15, 2007
Last Update Posted : February 20, 2015
Hadassah Medical Organization
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.